Article
XRCC4 glutarylation increases sensitivity to PARP inhibitors in breast cancer by inhibiting mTOR activity and promoting autophagy
2026-06-08
Abstract excerpt
<title>Abstract</title> <p> Background Glutarylation, a newly identified form of protein acylation, has been linked to the regulation of tumor metabolism. However, the role of glutarylation in breast cancer is currently unclear. Methods Multi-omics datasets analysis was employed to delineate the characteristics of XRCC4 in breast cancer. The roles of XRCC4 in breast cancer were validated using CCK-8, EdU, and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4967b03-4d95-540f-a251-1f24740337c6
- DOI
- 10.21203/rs.3.rs-9924119/v1
